GlassScriptPhysician profile
Linette Hubbell
NPI 1770959975
$1,032.85
in general payments reported to CMS, 2019-2025
17 companies · $48.53 in 2025
The $48.53 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $101 · 2021: $235 · 2022: $131 · 2023: $197 · 2024: $68.48 · 2025: $48.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $190.11 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $136.93 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $129.88 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $98.32 | 2019-2023 | Xarelto |
| Abbvie INC. | $97.28 | 2023-2025 | |
| Mylan Specialty L.P. | $82.23 | 2019-2022 | |
| Chiesi USA, INC. | $40.93 | 2019 | |
| Global Blood Therapeutics, INC. | $37.78 | 2021 | |
| Gilead Sciences, INC. | $34.35 | 2023 | Veklury |
| Amgen INC. | $33.78 | 2023 | Repatha |
| Inari Medical, INC. | $29.71 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bayer Healthcare Pharmaceuticals INC. | $28.70 | 2022 | |
| Alexion Pharmaceuticals, INC. | $24.48 | 2023 | Ultomiris |
| Vifor Pharma, INC. | $20.65 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.59 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.30 | 2020 | |
| Portola Pharmaceuticals, LLC | $14.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linette Hubbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.